Gastro-entero-pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: a therapy update
Gastro-entero-pancreatic neuroendocrine tumors (GEP-NETs) are the second most common tumors in multiple endocrine neoplasia type 1 (MEN1), mainly occurring in pancreatic islets and duodenum, usually as multiple tumors. They can manifest as both nonfunctioning and functioning tumors. Currently, surgi...
Saved in:
Published in | International journal of endocrine oncology Vol. 4; no. 1; pp. 43 - 58 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
London
Future Medicine Ltd
01.03.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Gastro-entero-pancreatic neuroendocrine tumors (GEP-NETs) are the second most common tumors in multiple endocrine neoplasia type 1 (MEN1), mainly occurring in pancreatic islets and duodenum, usually as multiple tumors. They can manifest as both nonfunctioning and functioning tumors. Currently, surgical removal of GEP-NETs in MEN1 represents the gold standard curative approach. Conventional medical therapies for sporadic GEP-NETs showed to be effective also in a percentage of MEN1 patients. Innovative medical therapies, that have demonstrated to be effective on sporadic GEP-NETs, still need to be evaluated on MEN1 patients in prospective clinical trials and long-term follow-up. This review resumes current knowledge of MEN1 GEP-NETs, discussing surgical and medical approaches, genetic and molecular bases of tumorigenesis, and presenting novel possible drug therapies. |
---|---|
AbstractList | Gastro-entero-pancreatic neuroendocrine tumors (GEP-NETs) are the second most common tumors in multiple endocrine neoplasia type 1 (MEN1), mainly occurring in pancreatic islets and duodenum, usually as multiple tumors. They can manifest as both nonfunctioning and functioning tumors. Currently, surgical removal of GEP-NETs in MEN1 represents the gold standard curative approach. Conventional medical therapies for sporadic GEP-NETs showed to be effective also in a percentage of MEN1 patients. Innovative medical therapies, that have demonstrated to be effective on sporadic GEP-NETs, still need to be evaluated on MEN1 patients in prospective clinical trials and long-term follow-up. This review resumes current knowledge of MEN1 GEP-NETs, discussing surgical and medical approaches, genetic and molecular bases of tumorigenesis, and presenting novel possible drug therapies. |
Author | Brandi, Maria Luisa Tonelli, Francesco Marini, Francesca Giusti, Francesca |
AuthorAffiliation | 1Department of Surgery & Translational Medicine, University of Florence, Florence, Italy |
AuthorAffiliation_xml | – name: 1Department of Surgery & Translational Medicine, University of Florence, Florence, Italy |
Author_xml | – sequence: 1 givenname: Francesco surname: Tonelli fullname: Tonelli, Francesco – sequence: 2 givenname: Francesca surname: Marini fullname: Marini, Francesca – sequence: 3 givenname: Francesca surname: Giusti fullname: Giusti, Francesca – sequence: 4 givenname: Maria Luisa surname: Brandi fullname: Brandi, Maria Luisa |
BookMark | eNp1kMFPwyAUh4mZiXPu6J3EMwq0lM6bWXSaLPGiZ0Lpq7J0UIEe9t_LUqOJyU7v8fh-kPddopnzDhC6ZvSWcybv7A4Ip6wilDJ5huacloLQWsrZb1-tLtAyxh3NiJAFk_UcfWx0TMETcAlyGbQzAXSyBjsYgwfXehOsA5zGvQ8RW4f3Y5_s0AP-u3Tgh15Hq3E6DIDZPc7dJwQ9HPA4tDrBFTrvdB9h-VMX6P3p8W39TLavm5f1w5YYXopE2EqbsgJeli1tG6BN0xSiNhKKpqyrPGEUjDSCa80rxoxooK047TrRtWVtRLFAN9O7Q_BfI8Skdn4MLn-psqZKlLySdaaKiTLBxxigU8amvLV3KWjbK0aPtFRZqjpKVUepOUX-pYZg9zocTvKrie_GNAaIxoIzoKbTHlprsrsT2W_Cz5DS |
CitedBy_id | crossref_primary_10_1080_21678707_2020_1811086 |
Cites_doi | 10.1530/EJE-11-0929 10.3748/wjg.v19.i45.8312 10.1200/JCO.2008.21.5988 10.1016/S0002-9440(10)61788-9 10.1016/j.ecl.2010.12.006 10.1210/jc.2012-1230 10.1530/EJE-14-0130 10.1002/humu.20605 10.1007/s00280-012-2055-z 10.1111/j.1365-2036.2009.04174.x 10.4251/wjgo.v8.i4.389 10.1159/000443167 10.1210/jc.2002-021314 10.1111/j.1365-2265.2008.03324.x 10.1007/s00259-013-2677-3 10.1016/j.beem.2015.09.004 10.1002/humu.21170 10.1111/jcmm.12552 10.1111/j.1365-2036.2011.04693.x 10.1136/bmjopen-2015-010765 10.1007/0-387-29512-7_7 10.1097/MD.0b013e3182954af1 10.1056/NEJMoa1316158 10.1210/jcem.86.12.8070 10.1073/pnas.0603877103 10.1016/B978-1-4160-5583-9.00150-7 10.1016/j.beem.2010.01.001 10.1136/gutjnl-2011-300831 10.1073/pnas.90.23.10914 10.1038/modpathol.2012.53 10.1016/j.beem.2015.10.005 10.1056/NEJMoa1003825 10.1111/cen.12411 10.1093/hmg/6.13.2285 10.1371/journal.pone.0039767 10.1007/s00428-007-0450-3 10.1210/jc.2008-2083 10.1016/S2213-8587(15)00043-1 10.1053/j.gastro.2013.10.020 10.1002/humu.21354 10.1530/EJE-14-0080 10.1200/JCO.2007.15.2553 10.1200/JCO.2004.04.024 10.1007/s00268-005-0354-9 10.1200/JCO.2009.22.8510 10.1016/j.ecl.2010.12.003 10.3109/02841868909111211 10.1371/journal.pgen.1003350 10.1056/NEJMc1406028 10.1002/cncr.25425 10.1007/s00259-014-2893-5 10.1128/MCB.24.15.6569-6580.2004 10.1152/ajpendo.00542.2013 10.1007/s00268-006-0360-y 10.1016/j.critrevonc.2015.11.003 10.1200/JCO.2005.08.066 10.1007/s00259-007-0691-z 10.1093/jnci/djs208 10.1056/NEJMoa1009290 10.1016/j.cancergen.2015.12.002 10.1038/modpathol.2010.58 10.5754/hge11212 10.1038/ng0897-375 10.1001/archderm.1997.03890430067009 10.1093/annonc/mdh216 |
ContentType | Journal Article |
Copyright | Future Medicine Ltd 2017. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: Future Medicine Ltd – notice: 2017. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | AAYXX CITATION 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S PHGZM PHGZT PIMPY PKEHL PQEST PQQKQ PQUKI |
DOI | 10.2217/ije-2016-0017 |
DatabaseName | CrossRef ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition |
DatabaseTitle | CrossRef Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) |
DatabaseTitleList | Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: 7X7 name: Health & Medical Collection url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2045-0877 |
EndPage | 58 |
ExternalDocumentID | 10_2217_ije_2016_0017 |
GroupedDBID | 3V. 7X7 8FI 8FJ ABUWG ACGFS ADBBV AFKRA ALMA_UNASSIGNED_HOLDINGS BBAFP BENPR BPHCQ BVXVI EBS EJD FYUFA H13 MV1 NTCAX PIMPY PQEST PQQKQ PROAC RFM 0YH 4.4 AAYXX ABJNI AGFEN ALIPV BCNDV CCPQU CITATION HMCUK OK1 PHGZM PHGZT TDBHL TFMDE TMEDX UKHRP 7XB 8FK AZQEC DWQXO K9. PKEHL PQUKI |
ID | FETCH-LOGICAL-c245t-19ac46e244d0dbe0bbb358c7e3b486dbe10ec7c52aa2611c5bed620ff5fd48c53 |
IEDL.DBID | 7X7 |
ISSN | 2045-0869 |
IngestDate | Sun Jun 29 16:10:34 EDT 2025 Thu Apr 24 22:56:57 EDT 2025 Tue Jul 01 01:27:20 EDT 2025 Tue Jan 05 21:42:19 EST 2021 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c245t-19ac46e244d0dbe0bbb358c7e3b486dbe10ec7c52aa2611c5bed620ff5fd48c53 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 |
OpenAccessLink | https://www.proquest.com/docview/2216542678?pq-origsite=%requestingapplication% |
PQID | 2216542678 |
PQPubID | 3747997 |
PageCount | 16 |
ParticipantIDs | proquest_journals_2216542678 crossref_citationtrail_10_2217_ije_2016_0017 crossref_primary_10_2217_ije_2016_0017 futurescience_futuremedicine_10_2217_ije_2016_0017 |
ProviderPackageCode | RFM NTCAX CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2017-March-01 2017-03-00 20170301 |
PublicationDateYYYYMMDD | 2017-03-01 |
PublicationDate_xml | – month: 03 year: 2017 text: 2017-March-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | London |
PublicationPlace_xml | – name: London |
PublicationTitle | International journal of endocrine oncology |
PublicationYear | 2017 |
Publisher | Future Medicine Ltd |
Publisher_xml | – name: Future Medicine Ltd |
References | e_1_3_2_28_1 e_1_3_2_49_1 e_1_3_2_20_1 e_1_3_2_41_1 e_1_3_2_66_1 e_1_3_2_22_1 e_1_3_2_43_1 Bordi C (e_1_3_2_52_1) 1995; 19 e_1_3_2_64_1 e_1_3_2_24_1 e_1_3_2_45_1 e_1_3_2_26_1 e_1_3_2_47_1 e_1_3_2_68_1 e_1_3_2_60_1 Tonelli F (e_1_3_2_46_1) 2016 e_1_3_2_16_1 e_1_3_2_39_1 e_1_3_2_9_1 e_1_3_2_7_1 Edge SB (e_1_3_2_10_1) 2010 e_1_3_2_31_1 e_1_3_2_54_1 e_1_3_2_33_1 e_1_3_2_75_1 e_1_3_2_12_1 e_1_3_2_35_1 e_1_3_2_58_1 e_1_3_2_5_1 e_1_3_2_14_1 e_1_3_2_37_1 e_1_3_2_56_1 e_1_3_2_3_1 Saif MW (e_1_3_2_44_1) 2013; 14 e_1_3_2_50_1 e_1_3_2_73_1 e_1_3_2_71_1 e_1_3_2_27_1 e_1_3_2_29_1 e_1_3_2_42_1 e_1_3_2_65_1 e_1_3_2_21_1 e_1_3_2_63_1 Zhuang Z (e_1_3_2_18_1) 1997; 57 e_1_3_2_23_1 e_1_3_2_69_1 e_1_3_2_25_1 e_1_3_2_48_1 e_1_3_2_67_1 e_1_3_2_61_1 e_1_3_2_40_1 e_1_3_2_17_1 e_1_3_2_38_1 e_1_3_2_8_1 Bosman F (e_1_3_2_11_1) 2010 Hessman O (e_1_3_2_19_1) 1998; 58 e_1_3_2_30_1 e_1_3_2_55_1 e_1_3_2_76_1 e_1_3_2_32_1 e_1_3_2_53_1 e_1_3_2_74_1 e_1_3_2_6_1 e_1_3_2_13_1 e_1_3_2_34_1 e_1_3_2_59_1 e_1_3_2_4_1 e_1_3_2_15_1 e_1_3_2_36_1 e_1_3_2_57_1 e_1_3_2_51_1 e_1_3_2_72_1 e_1_3_2_70_1 Qureshi SA (e_1_3_2_62_1) 2015; 46 |
References_xml | – ident: e_1_3_2_27_1 doi: 10.1530/EJE-11-0929 – ident: e_1_3_2_49_1 doi: 10.3748/wjg.v19.i45.8312 – ident: e_1_3_2_73_1 doi: 10.1200/JCO.2008.21.5988 – year: 2016 ident: e_1_3_2_46_1 article-title: Surgery for insulinomas in multiple endocrine neoplasia type 1: when pancreatoduodenectomy is appropriate publication-title: Surgery – volume: 58 start-page: 377 issue: 3 year: 1998 ident: e_1_3_2_19_1 article-title: Mutation of the multiple endocrine neoplasia type 1 gene in nonfamilial, malignant tumours of the endocrine pancreas publication-title: Cancer. Res. – ident: e_1_3_2_5_1 doi: 10.1016/S0002-9440(10)61788-9 – volume: 14 start-page: 498 issue: 5 year: 2013 ident: e_1_3_2_44_1 article-title: A retrospective study of capecitabine/temozolomide (CAPTEM) regimen in the treatment of metastatic pancreatic neuroendocrine tumours (pNETs) after failing previous therapy publication-title: JOP – ident: e_1_3_2_67_1 doi: 10.1016/j.ecl.2010.12.006 – ident: e_1_3_2_8_1 doi: 10.1210/jc.2012-1230 – ident: e_1_3_2_33_1 doi: 10.1530/EJE-14-0130 – ident: e_1_3_2_22_1 doi: 10.1002/humu.20605 – ident: e_1_3_2_43_1 doi: 10.1007/s00280-012-2055-z – ident: e_1_3_2_50_1 doi: 10.1111/j.1365-2036.2009.04174.x – ident: e_1_3_2_53_1 doi: 10.4251/wjgo.v8.i4.389 – ident: e_1_3_2_58_1 doi: 10.1159/000443167 – ident: e_1_3_2_51_1 doi: 10.1210/jc.2002-021314 – ident: e_1_3_2_15_1 doi: 10.1111/j.1365-2265.2008.03324.x – ident: e_1_3_2_65_1 doi: 10.1007/s00259-013-2677-3 – ident: e_1_3_2_47_1 doi: 10.1016/j.beem.2015.09.004 – ident: e_1_3_2_25_1 doi: 10.1002/humu.21170 – volume: 19 start-page: 175 issue: 1 year: 1995 ident: e_1_3_2_52_1 article-title: Hypergastrinemia and gastric entrocromaffin-like cells publication-title: Am. J. Surg. Pathol. – ident: e_1_3_2_34_1 doi: 10.1111/jcmm.12552 – ident: e_1_3_2_59_1 doi: 10.1111/j.1365-2036.2011.04693.x – volume: 46 start-page: e010765 issue: 5 year: 2015 ident: e_1_3_2_62_1 article-title: Screening for malnutrition in patients with gastro-entero-pancreatic neuroendocrine tumours: a cross-sectional study publication-title: BMJ Open doi: 10.1136/bmjopen-2015-010765 – ident: e_1_3_2_64_1 doi: 10.1007/0-387-29512-7_7 – volume-title: AJCC Cancer Staging Manual year: 2010 ident: e_1_3_2_10_1 – ident: e_1_3_2_14_1 doi: 10.1097/MD.0b013e3182954af1 – ident: e_1_3_2_55_1 doi: 10.1056/NEJMoa1316158 – ident: e_1_3_2_60_1 doi: 10.1056/NEJMoa1316158 – ident: e_1_3_2_3_1 doi: 10.1210/jcem.86.12.8070 – ident: e_1_3_2_31_1 doi: 10.1073/pnas.0603877103 – ident: e_1_3_2_48_1 doi: 10.1016/B978-1-4160-5583-9.00150-7 – ident: e_1_3_2_32_1 doi: 10.1016/j.beem.2010.01.001 – ident: e_1_3_2_45_1 doi: 10.1136/gutjnl-2011-300831 – ident: e_1_3_2_17_1 doi: 10.1073/pnas.90.23.10914 – ident: e_1_3_2_37_1 doi: 10.1038/modpathol.2012.53 – ident: e_1_3_2_69_1 doi: 10.1016/j.beem.2015.10.005 – ident: e_1_3_2_76_1 doi: 10.1056/NEJMoa1003825 – ident: e_1_3_2_57_1 doi: 10.1111/cen.12411 – ident: e_1_3_2_21_1 doi: 10.1093/hmg/6.13.2285 – ident: e_1_3_2_35_1 doi: 10.1371/journal.pone.0039767 – ident: e_1_3_2_9_1 doi: 10.1007/s00428-007-0450-3 – ident: e_1_3_2_30_1 doi: 10.1210/jc.2008-2083 – ident: e_1_3_2_16_1 doi: 10.1016/S2213-8587(15)00043-1 – ident: e_1_3_2_38_1 doi: 10.1053/j.gastro.2013.10.020 – ident: e_1_3_2_26_1 doi: 10.1002/humu.21354 – ident: e_1_3_2_29_1 doi: 10.1530/EJE-14-0080 – ident: e_1_3_2_66_1 doi: 10.1200/JCO.2007.15.2553 – ident: e_1_3_2_41_1 doi: 10.1200/JCO.2004.04.024 – ident: e_1_3_2_63_1 – ident: e_1_3_2_39_1 doi: 10.1007/s00268-005-0354-9 – ident: e_1_3_2_56_1 doi: 10.1200/JCO.2009.22.8510 – ident: e_1_3_2_68_1 doi: 10.1016/j.ecl.2010.12.003 – volume: 57 start-page: 4682 issue: 21 year: 1997 ident: e_1_3_2_18_1 article-title: Somatic mutations of the MEN1 tumour suppressor gene in sporadic gastrinomas and insulinomas publication-title: Cancer Res. – volume-title: WHO Classification of Tumours of the Digestive System year: 2010 ident: e_1_3_2_11_1 – ident: e_1_3_2_7_1 doi: 10.3109/02841868909111211 – ident: e_1_3_2_28_1 doi: 10.1371/journal.pgen.1003350 – ident: e_1_3_2_6_1 doi: 10.1056/NEJMc1406028 – ident: e_1_3_2_42_1 doi: 10.1002/cncr.25425 – ident: e_1_3_2_72_1 doi: 10.1007/s00259-014-2893-5 – ident: e_1_3_2_24_1 doi: 10.1128/MCB.24.15.6569-6580.2004 – ident: e_1_3_2_36_1 doi: 10.1152/ajpendo.00542.2013 – ident: e_1_3_2_40_1 doi: 10.1007/s00268-006-0360-y – ident: e_1_3_2_54_1 doi: 10.1016/j.critrevonc.2015.11.003 – ident: e_1_3_2_71_1 doi: 10.1200/JCO.2005.08.066 – ident: e_1_3_2_70_1 doi: 10.1007/s00259-007-0691-z – ident: e_1_3_2_12_1 doi: 10.1093/jnci/djs208 – ident: e_1_3_2_75_1 doi: 10.1056/NEJMoa1009290 – ident: e_1_3_2_23_1 doi: 10.1016/j.cancergen.2015.12.002 – ident: e_1_3_2_13_1 doi: 10.1038/modpathol.2010.58 – ident: e_1_3_2_74_1 doi: 10.5754/hge11212 – ident: e_1_3_2_20_1 doi: 10.1038/ng0897-375 – ident: e_1_3_2_4_1 doi: 10.1001/archderm.1997.03890430067009 – ident: e_1_3_2_61_1 doi: 10.1093/annonc/mdh216 |
SSID | ssj0001573178 |
Score | 1.9898605 |
Snippet | Gastro-entero-pancreatic neuroendocrine tumors (GEP-NETs) are the second most common tumors in multiple endocrine neoplasia type 1 (MEN1), mainly occurring in... |
SourceID | proquest crossref futurescience |
SourceType | Aggregation Database Enrichment Source Index Database Publisher |
StartPage | 43 |
SubjectTerms | Clinical trials genetic test GEP-NETs Localization Medical imaging medical therapy MEN1 Metastasis Mutation Neuroendocrine tumors NMR Nuclear magnetic resonance Pancreatic cancer Patients Polypeptides Proteins surgical therapy Tumorigenesis |
Title | Gastro-entero-pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: a therapy update |
URI | http://dx.doi.org/10.2217/ije-2016-0017 https://www.proquest.com/docview/2216542678 |
Volume | 4 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwEA-6gQgifuJ0jjyIT4a16bcvorI5hA0RB3srSZrJRNu5dv-_d21qEdGnfqQt9C65r9z9jpALUMJyzq2AuTLUzI24YEL7gkkhuAJJKRIb653HE380dR9n3swE3HKTVlnLxFJQJ5nCGHmfc6y74SBbb5afDLtG4e6qaaGxSdoIXYazOpgFTYzFC0A9lk3pwHJhYL1HFcwmfCzoL940zBEbHGqrbFfWqKWdCs_D6KBfUrpUPcM9smtsRnpbMXmfbOj0gGyNza74IXl9EHmxyhjCa8IB1ndlCipaolXqFP4Oi_xosf7IVjldpLTOI6TNYIq55FhTSTEsS-1rCmcV5gBdLzEwcESmw8HL_YiZBgpMcdcrmB0J5foaNHhiJVJbUkrHC1WgHemGPtyxLa0C5XFgjG_bypM68bk1n3vzxA2V5xyTVpql-oRQ8KF1JHHTFhZwAj4beGqWkA6YM6ELRl-HXNX0i5VBF8cmF-8xeBlI7hjIHSO5MYsu6JDL78eXFazGXw_yH8yIq6s68eCvl7o1x2KzJPO4mUCn_w-fkW2OurtMNOuSVrFa63OwPArZK6dXj7TvBpOn5y9289oM |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ZSwMxEA6lggoinlitmgf1ydDddK8KIuLV2uOphb6tSTYrFd3Wdov4p_yNzuxhEalvfdojuxAmwzfzJXMQcgJGWIbccJklPc2sGhdMaEcwKQRXgJQiMDHfud1x6j3rsW_3C-Qrz4XBsMocExOgDoYK98grnGPeDQdsvRq9M-wahaereQuNVC2a-vMDKNvksnEL63vK-f1d96bOsq4CTHHLjplZE8pyNJi1wAikNqSUVdtTrq5Ky3PgjWlo5Sqbw2wd01S21IHDjTC0w8DyFHaJAMhfAsNrINlz--5sT8d2wRwnTfDAU2LAFmppWU-YvFsZvGjQSRMIvJG0R5uZwbW0fkhm8_5YhcTU3W-Q9cxHpdepUm2Sgo62yHI7O4XfJs8PYhKPhwzLecIF8CR1PRVNqmPqCKSJSYU0nr4NxxM6iGget0hngxHGrmMOJ8VtYGpeULhLaxzQ6Qg3InZIbyGi3SXFaBjpPUKBs-uaxENiAIwAOCIwQ0PIKrhPngVOZomc5_LzVVbNHJtqvPrAalDcPojbR3Fj1J5bImc_n4_SMh7zPuS_FsNPn_JAh3k_lfMV8zMImPgzhd3_f_iYrNS77ZbfanSaB2SVo9-QBLmVSTEeT_UheD2xPEpUjZKnRev2N0ZQFy4 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ZS8NAEB6khSKIeGI990F9cmmyzVVBxKveRUTBt7i72YiiaW1TxL_mr3Mmh0VE33zKsQkks8M38-3OAbCORljFwvK5owLDnZaQXBpPciWl0IiUMrIp3_my453cOmd37t0YfJS5MBRWWWJiBtRRV9MaeUMIyrsRiK2NuAiLuDps7_ZeOXWQop3Wsp1GriLn5v0N6dtg5_QQ53pDiPbRzcEJLzoMcC0cN-V2S2rHM2jiIitSxlJKNd1A-6apnMDDO7ZltK9dgV_u2bZ2lYk8YcWxG0dOoKljBMJ_1SdWVIHq_lHn6nq0wuP6aJyzlnjoN3HkDq28yCf-it94fDKooTbSeStrljYyihN5NZHCAv6wEZnha0_BZOGxsr1cxaZhzCQzULss9uRn4eFYDtJ-l1NxTzwguuSOqGZZrUyToGwpxZClw5duf8AeE1ZGMbLRYEKR7JTRyWhRmNnbDM_yigds2KNliTm4_RfhzkMl6SZmARgyeNNStGWM8BEhY0SeaEnVRGcqcNDlrMNWKb9QF7XNqcXGc4gch8QdorhDEjfF8Pl12Px6vJcX9fjtQfFtMsL8qgx7-O2l5XLGwgIQBuFIfRf_Hl6DGup1eHHaOV-CcUFORBbxtgyVtD80K-gCpWq10DUG9_-t3p_IehzJ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Gastro-Entero-Pancreatic+Neuroendocrine+Tumors+in+Multiple+Endocrine+Neoplasia+Type+1%3A+A+Therapy+Update&rft.jtitle=International+journal+of+endocrine+oncology&rft.au=Tonelli%2C+Francesco&rft.au=Marini%2C+Francesca&rft.au=Giusti%2C+Francesca&rft.au=Brandi%2C+Maria+Luisa&rft.date=2017-03-01&rft.issn=2045-0869&rft.eissn=2045-0877&rft.volume=4&rft.issue=1&rft.spage=43&rft.epage=58&rft_id=info:doi/10.2217%2Fije-2016-0017&rft.externalDBID=n%2Fa&rft.externalDocID=10_2217_ije_2016_0017 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-0869&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-0869&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-0869&client=summon |